Vienna-based biotech research company Apeptico has successfully concluded its series C funding of EUR 3.4 mln, EUR 1.4 mln of which came in 2011 in the form of a research grant from the Austrian Research Promotion Agency. The remaining EUR 2 mln has come from The BioScience Venture Group, V+ GmbH & Co Fonds 2 KG [...]

CapMan Russia has made yet another investment, this time in Russian laboratory analysis equipment and chemical reagents for testing.

Rusnano, the Russian Federation’s USD 10 bln fund, is leading the field in the D series fund-raising for Selecta Biotech. The biopharmaceutical company will use the USD 22 mln round of funding to develop its research and development facilities, and expand the reach of its synthetic vaccine particle. An additional funding of USD 25 mln [...]

RusNano, the Russian nanotechnology investor established in 2007, has decided to infuse RUB 155 million into a new program aimed at developing tagged neutron detection systems. DViN, the applicant for approval of the project by the Supervisory Council of the Russian Corporation of Nanotechnologies, will contribute undisclosed intellectual property. The scientific base will come from [...]

Austria’s Biocrates Life Sciences AG, a leading international biotechnology company, recently announced the completion of the first tranche of a new round of fund raising which has garnered €1.2 million. The financing round was led by Arax Capital Partners and joined by others, MIG being among them. The company expects another infusion of financing later [...]

Nabriva Therapeutics, the Austrian biotechnology company based in Vienna, has announced the successful close of its second round of financing with €15 million in new funding. The two rounds combined for a total of €57.4 million for the company since its inception in 2006. The first round of funding consisted of a group of international [...]

Human Stem Cell Institute (HSCI), the Russian biotechnology company owned by Artur & Andrey Isaev and Alexander Prikhodko, has announced plans to offer an IPO to be listed on the MICEX Stock Exchange. The planned USD 5 million offering will be 15% to 25% of total HSCI shares and will be conducted later this year. [...]